vs
Bank First Corp（BFC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Bank First Corp的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.3倍（$44.9M vs $35.5M），Bank First Corp净利率更高（45.8% vs -304.2%，领先350.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 12.1%），Bank First Corp自由现金流更多（$51.0M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 9.1%）
First Horizon Corporation（前身为田纳西第一银行）是一家成立于1864年、总部位于美国田纳西州孟菲斯的金融服务企业。通过旗下子公司First Horizon银行，其业务覆盖美国东南部12个州，是该区域第四大区域性银行。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BFC vs RXRX — 直观对比
营收规模更大
BFC
是对方的1.3倍
$35.5M
营收增速更快
RXRX
高出669.6%
12.1%
净利率更高
BFC
高出350.0%
-304.2%
自由现金流更多
BFC
多$98.4M
$-47.3M
两年增速更快
RXRX
近两年复合增速
9.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.9M | $35.5M |
| 净利润 | $18.4M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 51.0% | -304.8% |
| 净利率 | 45.8% | -304.2% |
| 营收同比 | 12.1% | 681.7% |
| 净利润同比 | 4.8% | 39.6% |
| 每股收益（稀释后） | $1.87 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFCRXRX
| Q4 25 | $44.9M | $35.5M | ||
| Q3 25 | $44.2M | $5.2M | ||
| Q2 25 | $41.6M | $19.2M | ||
| Q1 25 | $43.1M | $14.7M | ||
| Q4 24 | $40.1M | $4.5M | ||
| Q3 24 | $40.8M | $26.1M | ||
| Q2 24 | $38.9M | $14.4M | ||
| Q1 24 | $37.7M | $13.8M |
净利润BFCRXRX
| Q4 25 | $18.4M | $-108.1M | ||
| Q3 25 | $18.0M | $-162.3M | ||
| Q2 25 | $16.9M | $-171.9M | ||
| Q1 25 | $18.2M | $-202.5M | ||
| Q4 24 | $17.5M | $-178.9M | ||
| Q3 24 | $16.6M | $-95.8M | ||
| Q2 24 | $16.1M | $-97.5M | ||
| Q1 24 | $15.4M | $-91.4M |
毛利率BFCRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率BFCRXRX
| Q4 25 | 51.0% | -304.8% | ||
| Q3 25 | 50.8% | -3327.6% | ||
| Q2 25 | 49.7% | -916.8% | ||
| Q1 25 | 51.3% | -1297.9% | ||
| Q4 24 | 54.4% | -4042.4% | ||
| Q3 24 | 50.7% | -377.1% | ||
| Q2 24 | 51.0% | -697.4% | ||
| Q1 24 | 45.6% | -698.4% |
净利率BFCRXRX
| Q4 25 | 45.8% | -304.2% | ||
| Q3 25 | 40.7% | -3135.3% | ||
| Q2 25 | 40.5% | -894.2% | ||
| Q1 25 | 42.3% | -1373.3% | ||
| Q4 24 | 49.3% | -3935.5% | ||
| Q3 24 | 40.6% | -367.5% | ||
| Q2 24 | 41.3% | -676.6% | ||
| Q1 24 | 40.8% | -662.4% |
每股收益（稀释后）BFCRXRX
| Q4 25 | $1.87 | $-0.17 | ||
| Q3 25 | $1.83 | $-0.36 | ||
| Q2 25 | $1.71 | $-0.41 | ||
| Q1 25 | $1.82 | $-0.50 | ||
| Q4 24 | $1.75 | $-0.56 | ||
| Q3 24 | $1.65 | $-0.34 | ||
| Q2 24 | $1.59 | $-0.40 | ||
| Q1 24 | $1.51 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $243.2M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $643.8M | $1.1B |
| 总资产 | $4.5B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资BFCRXRX
| Q4 25 | $243.2M | $743.3M | ||
| Q3 25 | $126.2M | $659.8M | ||
| Q2 25 | $120.3M | $525.1M | ||
| Q1 25 | $300.9M | $500.5M | ||
| Q4 24 | $261.3M | $594.4M | ||
| Q3 24 | $204.4M | $427.6M | ||
| Q2 24 | $99.0M | $474.3M | ||
| Q1 24 | $83.4M | $296.3M |
总债务BFCRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益BFCRXRX
| Q4 25 | $643.8M | $1.1B | ||
| Q3 25 | $628.1M | $1.0B | ||
| Q2 25 | $612.3M | $919.1M | ||
| Q1 25 | $648.4M | $933.9M | ||
| Q4 24 | $639.7M | $1.0B | ||
| Q3 24 | $628.9M | $524.6M | ||
| Q2 24 | $614.6M | $584.4M | ||
| Q1 24 | $609.3M | $401.2M |
总资产BFCRXRX
| Q4 25 | $4.5B | $1.5B | ||
| Q3 25 | $4.4B | $1.4B | ||
| Q2 25 | $4.4B | $1.3B | ||
| Q1 25 | $4.5B | $1.3B | ||
| Q4 24 | $4.5B | $1.4B | ||
| Q3 24 | $4.3B | $726.5M | ||
| Q2 24 | $4.1B | $775.9M | ||
| Q1 24 | $4.1B | $557.8M |
负债/权益比BFCRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $62.5M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $51.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | 113.6% | -133.1% |
| 资本支出强度资本支出/营收 | 25.5% | 3.5% |
| 现金转化率经营现金流/净利润 | 3.40× | — |
| 过去12个月自由现金流最近4个季度 | $75.8M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流BFCRXRX
| Q4 25 | $62.5M | $-46.1M | ||
| Q3 25 | $15.5M | $-117.4M | ||
| Q2 25 | $11.9M | $-76.4M | ||
| Q1 25 | $6.2M | $-132.0M | ||
| Q4 24 | $65.8M | $-115.4M | ||
| Q3 24 | $18.8M | $-59.2M | ||
| Q2 24 | $14.9M | $-82.2M | ||
| Q1 24 | $1.3M | $-102.3M |
自由现金流BFCRXRX
| Q4 25 | $51.0M | $-47.3M | ||
| Q3 25 | $12.5M | $-117.6M | ||
| Q2 25 | $8.2M | $-79.6M | ||
| Q1 25 | $4.0M | $-133.8M | ||
| Q4 24 | $58.6M | $-116.7M | ||
| Q3 24 | $16.9M | $-63.8M | ||
| Q2 24 | $13.7M | $-83.4M | ||
| Q1 24 | $551.0K | $-109.0M |
自由现金流率BFCRXRX
| Q4 25 | 113.6% | -133.1% | ||
| Q3 25 | 28.2% | -2272.5% | ||
| Q2 25 | 19.8% | -413.9% | ||
| Q1 25 | 9.3% | -907.4% | ||
| Q4 24 | 146.3% | -2567.7% | ||
| Q3 24 | 41.5% | -244.6% | ||
| Q2 24 | 35.3% | -578.5% | ||
| Q1 24 | 1.5% | -789.9% |
资本支出强度BFCRXRX
| Q4 25 | 25.5% | 3.5% | ||
| Q3 25 | 6.7% | 4.7% | ||
| Q2 25 | 8.7% | 16.4% | ||
| Q1 25 | 5.0% | 12.4% | ||
| Q4 24 | 18.0% | 28.6% | ||
| Q3 24 | 4.5% | 17.5% | ||
| Q2 24 | 3.1% | 8.2% | ||
| Q1 24 | 2.1% | 48.2% |
现金转化率BFCRXRX
| Q4 25 | 3.40× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 3.75× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 0.09× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
